Paul Reilly

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

Charles V. Pollack, Paul Reilly, Joanne van Ryn et al. · New England Journal of Medicine · 2017 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

John W. Eikelboom, Lars Wallentin, Stuart J. Connolly et al. · Circulation · 2011 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

Lars Wallentin, Salim Yusuf, Michael D. Ezekowitz et al. · The Lancet · 2010 · 1K citations

Medicine, Cardiology, Pharmacology +15

The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients

Paul Reilly, Thorsten Lehr, Sebastian Haertter et al. · Journal of the American College of Cardiology · 2013 · 826 citations

Medicine, Cardiology, Pharmacology +17